Sara Suliman
Overview
Explore the profile of Sara Suliman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1781
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suliman S, Agyei L, Afzal S, Williams S
Trends Immunol
. 2025 Jan;
46(2):100-103.
PMID: 39843309
Community engagement is essential for shaping equitable biomedical research priorities, but it is often underutilized, especially for marginalized populations. To integrate community feedback from the public into research, herein we...
2.
Suliman S, Ellaithi M
Prostate Cancer
. 2024 Dec;
2024:4406057.
PMID: 39735939
Prostate cancer is the most common noncutaneous malignancy among men worldwide, including in Sudan, where it represents a significant public health challenge. CD147, a transmembrane glycoprotein implicated in tumor progression,...
3.
Osman A, Morsi A, El-Refee S, Suliman S
J Pediatr Endocrinol Metab
. 2024 Sep;
37(12):1096-1099.
PMID: 39258502
Objectives: To present the clinical journey and management of a 15-year-old female with SHORT syndrome, highlighting the diagnostic challenges and the novel genetic mutation identified. Case Presentation: A 15-year-old Filipino...
4.
Suliman S, Maison D, Henrich T
Nat Immunol
. 2024 Sep;
25(10):1765-1769.
PMID: 39242838
No abstract available.
5.
Darboe F, Reijneveld J, Maison D, Martinez L, Suliman S
Trends Immunol
. 2024 Aug;
45(9):649-661.
PMID: 39181733
Tuberculosis (TB) is a leading cause of mortality from an infectious disease. In this opinion article, we focus on accumulating scientific evidence indicating that viral infections may contribute to TB...
6.
Nieto-Caballero V, Reijneveld J, Ruvalcaba A, Innocenzi G, Abeydeera N, Asgari S, et al.
PLoS Genet
. 2024 Jun;
20(6):e1011313.
PMID: 38870230
A quarter of humanity is estimated to have been exposed to Mycobacterium tuberculosis (Mtb) with a 5-10% risk of developing tuberculosis (TB) disease. Variability in responses to Mtb infection could...
7.
Buckley A, Suliman S, Allum M, Mohammed N, Lessan N, le Roux C, et al.
Diabetes Obes Metab
. 2024 May;
26(8):3381-3391.
PMID: 38783825
Aim: Tirzepatide is a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) dual receptor agonist (RA) that reduces glycated haemoglobin (HbA1c) and weight in patients with type 2 diabetes. We assessed...
8.
Kotov D, Lee O, Ji D, Jaye D, Suliman S, Gabay C, et al.
bioRxiv
. 2023 Nov;
PMID: 37961447
( ) causes 1.6 million deaths a year . However, no individual mouse model fully recapitulates the hallmarks of human tuberculosis disease. Here we report that a comparison across three...
9.
Suliman S, Nieto-Caballero V, Asgari S, Lopez K, Iwany S, Luo Y, et al.
medRxiv
. 2023 Jul;
PMID: 37425785
A quarter of humanity is estimated to be latently infected with () with a 5-10% risk of developing tuberculosis (TB) disease. Variability in responses to infection could be due to...
10.
Suliman S
Cell Host Microbe
. 2023 Jun;
31(6):921-923.
PMID: 37321176
In this issue of Cell Host & Microbe, Darrah et al. define immune responses against Mycobacterium tuberculosis (Mtb) infection following intravenous Bacille-Calmette Guérin (BCG) vaccination of nonhuman primates. The results...